Public Health Surveillance for COVID-19: Interim guidance
22
23.
Unity Studies: Early Investigation Protocols. Accessed April 21, 2021. https://www.who.int/emergencies/diseases/novel-
coronavirus-2019/technical-guidance/early-investigations
24.
WOrld Health Organisation. A clinical Case definition of Post Covid-19 Condition by a DELPHI consensus. Published
October 6, 2021. Accessed November 9, 2021. moz-
extension://6aec06a7
-
94b7
-4699-
8677
-04292e68a848/enhanced-
reader.html?openApp&pdf=https%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F345824%2F
WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf
25.
Diagnostic testing for SARS-CoV-2. Accessed April 21, 2021. https://www.who.int/publications/i/item/diagnostic-testing-
for-sars-cov-2
26.
The SARS-CoV-2 Antigen RDT Training Package | HSLP. Accessed December 15, 2021.
https://extranet.who.int/hslp/content/sars-cov-2-antigen-rapid-diagnostic-test-training-package
27.
Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. Accessed April 21, 2021.
https://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-
immunoassays
28.
Use of antigen detection rapid diagnostic testing. Accessed December 15, 2021. https://www.who.int/multi-
media/details/use-of-antigen-detection-rapid-diagnostic-testing
29.
Advice on the use of point-of-care immunodiagnostic tests for COVID-19: scientific brief. Accessed November 9, 2021.
https://www.who.int/publications/i/item/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19-
scientific-brief
30.
SARS-CoV-2 genomic sequencing for public health goals: Interim guidance, 8 January 2021. Accessed April 21, 2021.
https://www.who.int/publications/i/item/WHO-2019-nCoV-genomic_sequencing-2021.1
31.
Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities. Accessed November 9, 2021.
https://www.who.int/publications/i/item/WHO-2019-nCoV-lab-testing-2021.1-eng
32.
Global epidemiological surveillance standards for influenza. Accessed November 11, 2021.
https://www.who.int/publications/i/item/9789241506601
33.
Corrigenda – Maintaining surveillance of influenza and monitoring SARS-CoV-2. Accessed November 8, 2021.
https://www.who.int/publications/m/item/corrigenda
34.
Surveillance protocol for SARS-CoV-2 infection among health workers. Accessed November 11, 2021.
https://www.who.int/publications/i/item/WHO-2019-nCoV-HCW_Surveillance_Protocol-2020.1
35.
Cohort study to measure COVID-19 vaccine effectiveness among health workers in the WHO European Region: guidance
document. Accessed December 7, 2021. https://apps.who.int/iris/handle/10665/340217?search
-
result=true&query=WHO%2FEURO%3A2021
-2141-41896-
57484&scope=&rpp=10&sort_by=score&order=desc
36.
Protocol for assessment of potential risk factors for 2019-novel coronavirus (COVID-19) infection among health care
workers in a health care setting. Accessed November 11, 2021. https://www.who.int/publications/i/item/protocol-for-
assessment-of-potential-risk-factors-for-2019-novel-coronavirus-(2019-ncov)-infection-among-health-care-workers-in-a-
health-care-setting
37.
Revealing the toll of COVID-19. Accessed November 15, 2021. https://www.who.int/publications/i/item/revealing-the-
toll-of-covid-19
38.
The true death toll of COVID-19: estimating global excess mortality. Accessed November 15, 2021.
https://www.who.int/data/stories/the-true-death-toll-of-covid-19-estimating-global-excess-mortality
39.
Verbal autopsy standard. Accessed November 15, 2021. https://www.who.int/standards/classifications/other-
classifications/verbal-autopsy-standards-ascertaining-and-attributing-causes-of-death-tool
40.
Estimating COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated
with laboratory-confirmed SARS-CoV-2: an evaluation using the test-negative design: guidance document. Accessed
February 11, 2022. https://apps.who.int/iris/handle/10665/341111
41.
Early detection, verification, assessment and communication. Accessed November 15, 2021.
https://www.who.int/initiatives/eios
42.
Africa CDC Event-based Surveillance Framework – Africa CDC. Accessed November 15, 2021.
https://africacdc.org/download/africa-cdc-event-based-surveillance-framework/
43.
Menni C, Valdes AM, Freidin MB, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19.
Nat Med
. 2020;26(7):1037
-1040. doi:10.1038/s41591-020-0916-2
44.
Do'stlaringiz bilan baham: 
